Agios Pharmaceuticals
AGIO
#4268
Rank
ยฃ1.60 B
Marketcap
ยฃ28.20
Share price
-1.09%
Change (1 day)
56.39%
Change (1 year)

Revenue for Agios Pharmaceuticals (AGIO)

Revenue in 2024 (TTM): ยฃ24.82 Million

According to Agios Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is ยฃ25.19 Million. In 2023 the company made a revenue of ยฃ21.05 Million an increase over the revenue in the year 2022 that were of ยฃ11.77 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Agios Pharmaceuticals from 2012 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ24.82 M17.91%
2023 ยฃ21.05 M78.87%
2022 ยฃ11.77 M
2021 N/A-100%
2020 ยฃ32.31 M-64.06%
2019 ยฃ89.91 M20.93%
2018 ยฃ74.35 M133.65%
2017 ยฃ31.82 M-43.82%
2016 ยฃ56.64 M41.99%
2015 ยฃ39.89 M-4.97%
2014 ยฃ41.97 M171.04%
2013 ยฃ15.48 M-0.29%
2012 ยฃ15.53 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ67.79 M 169.04%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.65 B 6,475.89%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ47.85 B 189,794.17%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ2.19 B 8,596.28%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ32.04 B 127,060.66%๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ32.52 B 128,989.56%๐Ÿ‡บ๐Ÿ‡ธ USA